Description: * Tesamorlin is a stabilized synthetic peptide analog of Growth Hormone-Releasing Factor (GRF), specifically structured to clear resistant deep visceral fat accumulations.
It acts with precision on pituitary somatotroph cells, prompting the synthesis and secretion of endogenous growth hormone without disrupting glucose homeostasis.
The resultant increase in IGF-1 profiles triggers intense lipolysis within deep abdominal and visceral walls, drastically optimizing structural body composition metrics.
Academic models highlight its capacity to improve lipid profiles and vascular inflammatory markers while avoiding anabolic side effects common in non-selective therapies.
An advanced biochemical sequence optimized for metabolic research, cardiovascular health, and localized visceral fat degradation.
Reviews
There are no reviews yet.